In an era where health is wealth, and the global healthcare sector is booming like never before, savvy investors are looking for opportunities that promise growth and a meaningful impact on people’s lives. Enter Novartis AG—a powerhouse in pharmaceuticals that’s not only redefining treatments but also setting new standards in innovation and sustainability.
A strong monthly demand imbalance at $97.13 per share has recently taken control. Expecting a decent reaction from this price level in the following weeks.
A strong monthly demand imbalance at $97.13 per share has recently taken control. Expecting a decent reaction from this price level in the following weeks.
Alfonso Moreno
Set and Forget Trading Academy
Set and Forget Trading Academy
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Alfonso Moreno
Set and Forget Trading Academy
Set and Forget Trading Academy
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.